Cargando…
PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION.
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429631/ http://dx.doi.org/10.1097/01.HS9.0000977252.70104.05 |
_version_ | 1785090763195940864 |
---|---|
author | Monard, Amaury Heubel-Moenen, Fs.C.J.I. Castoldi, Elisabetta De Simone, Ilaria van der Meijden, P.E.J. Wichapong, Kanin van Doorn, W.P.T.M. Spada, Stefano Hellenbrand, D.L.S. Stork, A.D.M. Cate, Hugo Ten Beckers, E.A.M. Henskens, Y.M.C. |
author_facet | Monard, Amaury Heubel-Moenen, Fs.C.J.I. Castoldi, Elisabetta De Simone, Ilaria van der Meijden, P.E.J. Wichapong, Kanin van Doorn, W.P.T.M. Spada, Stefano Hellenbrand, D.L.S. Stork, A.D.M. Cate, Hugo Ten Beckers, E.A.M. Henskens, Y.M.C. |
author_sort | Monard, Amaury |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10429631 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104296312023-08-17 PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. Monard, Amaury Heubel-Moenen, Fs.C.J.I. Castoldi, Elisabetta De Simone, Ilaria van der Meijden, P.E.J. Wichapong, Kanin van Doorn, W.P.T.M. Spada, Stefano Hellenbrand, D.L.S. Stork, A.D.M. Cate, Hugo Ten Beckers, E.A.M. Henskens, Y.M.C. Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10429631/ http://dx.doi.org/10.1097/01.HS9.0000977252.70104.05 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Monard, Amaury Heubel-Moenen, Fs.C.J.I. Castoldi, Elisabetta De Simone, Ilaria van der Meijden, P.E.J. Wichapong, Kanin van Doorn, W.P.T.M. Spada, Stefano Hellenbrand, D.L.S. Stork, A.D.M. Cate, Hugo Ten Beckers, E.A.M. Henskens, Y.M.C. PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. |
title | PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. |
title_full | PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. |
title_fullStr | PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. |
title_full_unstemmed | PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. |
title_short | PB2642: EVALUATION OF INNOVATIVE LABORATORY TESTS TO PREDICT A THROMBOTIC PHENOTYPE IN A FAMILY WITH DYSFIBRINOGENEMIA AND A NOVEL FGG MUTATION. |
title_sort | pb2642: evaluation of innovative laboratory tests to predict a thrombotic phenotype in a family with dysfibrinogenemia and a novel fgg mutation. |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429631/ http://dx.doi.org/10.1097/01.HS9.0000977252.70104.05 |
work_keys_str_mv | AT monardamaury pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT heubelmoenenfscji pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT castoldielisabetta pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT desimoneilaria pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT vandermeijdenpej pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT wichapongkanin pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT vandoornwptm pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT spadastefano pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT hellenbranddls pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT storkadm pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT catehugoten pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT beckerseam pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation AT henskensymc pb2642evaluationofinnovativelaboratoryteststopredictathromboticphenotypeinafamilywithdysfibrinogenemiaandanovelfggmutation |